The Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Department of Health and Human Services.
Notice of Meeting.Start Printed Page 7570
The Presidential Commission for the Study of Bioethical Issues will conduct its fourth meeting. At this meeting, the Commission will discuss genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. The Commission will also begin a review of human subjects protection.
The meeting will take place Monday, February 28, 2011, from 9 a.m. to approximately 4:30 p.m., and Tuesday, March 1, 2011, from 9 a.m. to approximately 12:30 p.m.
The St. Regis Hotel, Washington, DC, 923 16th and K Streets, NW., Washington, DC 20006. Phone 202-638-2626.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications Director, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue, NW., Suite C-100, Washington, DC 20005. Telephone: 202-233-3963. E-mail: Hillary.Viers@bioethics.gov. Additional information may be obtained at http://www.bioethics.gov.End Further Info End Preamble Start Supplemental Information
Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given of the fourth meeting of the Presidential Commission for the Study of Bioethical Issues (PCSBI). The meeting will be held from 9 a.m. to approximately 4:30 p.m. on Monday, February 28, 2011, and from 9 a.m. to approximately 12:30 p.m. on Tuesday, March 1, 2011, at the St. Regis Hotel, Washington, DC. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at http://www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009, the President established PCSBI to serve as a public forum and advise him on bioethical issues generated by novel and emerging research in biomedicine and related areas of science and technology. The Commission is charged to identify and promote policies and practices that assure ethically responsible conduct of scientific research, healthcare delivery, and technological innovation. In undertaking these duties, the Commission will examine specific bioethical, legal, and social issues related to potential scientific and technological advances; examine diverse perspectives and possibilities for useful international collaboration on these issues; and recommend legal, regulatory, or policy actions as appropriate.
The main agenda items for this fourth meeting involve genetics, neuroscience, and neuroimaging; and a review of human subjects protection. Specifically, the Commission is interested in exploring social and ethical issues involving genetics, neuroscience, and neuroimaging used for research, diagnosis, risk identification, and prevention. The Commission will also begin its review of human subjects protection as requested by President Obama on November 24, 2010.
The draft meeting agenda and other information about PCSBI, including information about access to the webcast, will be available at http://www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public comment on any issue before it. The Commission's goal, time permitting, is to invite brief public comment during each meeting session. Individuals who would like to provide public comment at the meeting should notify Esther Yoo by telephone at 202-233-3960, or e-mail at Esther.Yoo@bioethics.gov. To accommodate as many speakers as possible the time for public comments may be limited. If the number of individuals wishing to speak is greater than can reasonably be accommodated during the scheduled meeting, the Commission may randomly select speakers from among those who register to speak.
Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should also notify Esther Yoo (contact information above) in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance.
Written comments will also be accepted and are especially welcome. Please address written comments by e-mail to email@example.com, or by mail to the following address: Public Commentary, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Ave., NW., Suite C-100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted.Start Signature
Dated: February 2, 2011.
Valerie H. Bonham,
Executive Director, The Presidential Commission for the Study of Bioethical Issues.
[FR Doc. 2011-3023 Filed 2-9-11; 8:45 am]
BILLING CODE 4154-06-P